Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 01:18:33 UTC
Update Date2021-09-26 22:58:15 UTC
HMDB IDHMDB0248139
Secondary Accession NumbersNone
Metabolite Identification
Common NameAlisertib
DescriptionAlisertib, also known as MLN8237, belongs to the class of organic compounds known as benzazepines. These are organic compounds containing a benzene ring fused to an azepine ring (unsaturated seven-membered heterocycle with one nitrogen atom replacing a carbon atom). Alisertib is a drug which is used for the treatment of various forms of cancer. Based on a literature review a significant number of articles have been published on Alisertib. This compound has been identified in human blood as reported by (PMID: 31557052 ). Alisertib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Alisertib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
MLN8237HMDB
4-{[13-chloro-10-(2-fluoro-6-methoxyphenyl)-3,5,9-triazatricyclo[9.4.0.0²,⁷]pentadeca-1(11),2,4,6,9,12,14-heptaen-4-yl]amino}-2-methoxybenzoateHMDB
Chemical FormulaC27H20ClFN4O4
Average Molecular Weight518.93
Monoisotopic Molecular Weight518.115711
IUPAC Name4-{[13-chloro-10-(2-fluoro-6-methoxyphenyl)-3,5,9-triazatricyclo[9.4.0.0^{2,7}]pentadeca-1(11),2,4,6,9,12,14-heptaen-4-yl]amino}-2-methoxybenzoic acid
Traditional Name4-{[13-chloro-10-(2-fluoro-6-methoxyphenyl)-3,5,9-triazatricyclo[9.4.0.0^{2,7}]pentadeca-1(11),2,4,6,9,12,14-heptaen-4-yl]amino}-2-methoxybenzoic acid
CAS Registry NumberNot Available
SMILES
COC1=CC(NC2=NC=C3CN=C(C4=C(C=CC(Cl)=C4)C3=N2)C2=C(F)C=CC=C2OC)=CC=C1C(O)=O
InChI Identifier
InChI=1S/C27H20ClFN4O4/c1-36-21-5-3-4-20(29)23(21)25-19-10-15(28)6-8-17(19)24-14(12-30-25)13-31-27(33-24)32-16-7-9-18(26(34)35)22(11-16)37-2/h3-11,13H,12H2,1-2H3,(H,34,35)(H,31,32,33)
InChI KeyZLHFILGSQDJULK-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as benzazepines. These are organic compounds containing a benzene ring fused to an azepine ring (unsaturated seven-membered heterocycle with one nitrogen atom replacing a carbon atom).
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassBenzazepines
Sub ClassNot Available
Direct ParentBenzazepines
Alternative Parents
Substituents
  • Benzazepine
  • O-methoxybenzoic acid or derivatives
  • Benzoic acid or derivatives
  • Benzoic acid
  • Methoxyaniline
  • Phenoxy compound
  • Anisole
  • Benzoyl
  • Methoxybenzene
  • Aniline or substituted anilines
  • Phenol ether
  • Alkyl aryl ether
  • Aminopyrimidine
  • Azepine
  • Fluorobenzene
  • Halobenzene
  • Aryl chloride
  • Aryl fluoride
  • Aryl halide
  • Monocyclic benzene moiety
  • Benzenoid
  • Pyrimidine
  • Heteroaromatic compound
  • Amino acid or derivatives
  • Ketimine
  • Amino acid
  • Secondary amine
  • Monocarboxylic acid or derivatives
  • Propargyl-type 1,3-dipolar organic compound
  • Organic 1,3-dipolar compound
  • Ether
  • Carboxylic acid
  • Carboxylic acid derivative
  • Azacycle
  • Organohalogen compound
  • Hydrocarbon derivative
  • Organic oxygen compound
  • Imine
  • Organic oxide
  • Organopnictogen compound
  • Amine
  • Organic nitrogen compound
  • Organochloride
  • Organofluoride
  • Organonitrogen compound
  • Organooxygen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP5ALOGPS
logP5.5ChemAxon
logS-5.5ALOGPS
pKa (Strongest Acidic)4.28ChemAxon
pKa (Strongest Basic)3.01ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count8ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area105.93 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity137.21 m³·mol⁻¹ChemAxon
Polarizability52.18 ųChemAxon
Number of Rings5ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+216.29430932474
DeepCCS[M-H]-213.89930932474
DeepCCS[M-2H]-246.78230932474
DeepCCS[M+Na]+222.20730932474
AllCCS[M+H]+220.832859911
AllCCS[M+H-H2O]+218.832859911
AllCCS[M+NH4]+222.632859911
AllCCS[M+Na]+223.132859911
AllCCS[M-H]-207.932859911
AllCCS[M+Na-2H]-207.932859911
AllCCS[M+HCOO]-208.032859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
AlisertibCOC1=CC(NC2=NC=C3CN=C(C4=C(C=CC(Cl)=C4)C3=N2)C2=C(F)C=CC=C2OC)=CC=C1C(O)=O6164.2Standard polar33892256
AlisertibCOC1=CC(NC2=NC=C3CN=C(C4=C(C=CC(Cl)=C4)C3=N2)C2=C(F)C=CC=C2OC)=CC=C1C(O)=O4357.7Standard non polar33892256
AlisertibCOC1=CC(NC2=NC=C3CN=C(C4=C(C=CC(Cl)=C4)C3=N2)C2=C(F)C=CC=C2OC)=CC=C1C(O)=O4656.0Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Alisertib,2TMS,isomer #1COC1=CC(N(C2=NC=C3CN=C(C4=C(F)C=CC=C4OC)C4=CC(Cl)=CC=C4C3=N2)[Si](C)(C)C)=CC=C1C(=O)O[Si](C)(C)C4233.5Semi standard non polar33892256
Alisertib,2TMS,isomer #1COC1=CC(N(C2=NC=C3CN=C(C4=C(F)C=CC=C4OC)C4=CC(Cl)=CC=C4C3=N2)[Si](C)(C)C)=CC=C1C(=O)O[Si](C)(C)C3923.3Standard non polar33892256
Alisertib,2TMS,isomer #1COC1=CC(N(C2=NC=C3CN=C(C4=C(F)C=CC=C4OC)C4=CC(Cl)=CC=C4C3=N2)[Si](C)(C)C)=CC=C1C(=O)O[Si](C)(C)C5620.3Standard polar33892256
Alisertib,2TBDMS,isomer #1COC1=CC(N(C2=NC=C3CN=C(C4=C(F)C=CC=C4OC)C4=CC(Cl)=CC=C4C3=N2)[Si](C)(C)C(C)(C)C)=CC=C1C(=O)O[Si](C)(C)C(C)(C)C4509.3Semi standard non polar33892256
Alisertib,2TBDMS,isomer #1COC1=CC(N(C2=NC=C3CN=C(C4=C(F)C=CC=C4OC)C4=CC(Cl)=CC=C4C3=N2)[Si](C)(C)C(C)(C)C)=CC=C1C(=O)O[Si](C)(C)C(C)(C)C4274.9Standard non polar33892256
Alisertib,2TBDMS,isomer #1COC1=CC(N(C2=NC=C3CN=C(C4=C(F)C=CC=C4OC)C4=CC(Cl)=CC=C4C3=N2)[Si](C)(C)C(C)(C)C)=CC=C1C(=O)O[Si](C)(C)C(C)(C)C5590.6Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Alisertib GC-MS (TMS_1_1) - 70eV, PositiveNot Available2021-11-03Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Alisertib GC-MS (TMS_1_2) - 70eV, PositiveNot Available2021-11-03Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Alisertib GC-MS (TBDMS_1_1) - 70eV, PositiveNot Available2021-11-03Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Alisertib GC-MS (TBDMS_1_2) - 70eV, PositiveNot Available2021-11-03Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Alisertib 10V, Positive-QTOFsplash10-0gbc-0007490000-b783c9395803155f661f2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Alisertib 20V, Positive-QTOFsplash10-0v4i-0203950000-1598ef392956d6a5bc612017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Alisertib 40V, Positive-QTOFsplash10-01pd-0129100000-8bb7f5146da50ecf2dae2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Alisertib 10V, Negative-QTOFsplash10-01b9-0000890000-fb73a16c216c6ae225ae2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Alisertib 20V, Negative-QTOFsplash10-05fr-0100920000-bc27235f15a7cffc148a2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Alisertib 40V, Negative-QTOFsplash10-0a4i-1201900000-d8f3e0910ba1f8b308332017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Alisertib 10V, Positive-QTOFsplash10-0udi-0000090000-82636c44d0f033f634c02021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Alisertib 20V, Positive-QTOFsplash10-0udi-0000290000-d7c967c03d3d5b420cc02021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Alisertib 40V, Positive-QTOFsplash10-05fu-0303910000-8046712394df14e60d402021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Alisertib 10V, Negative-QTOFsplash10-014i-0000390000-428f8978a81c483fdcd92021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Alisertib 20V, Negative-QTOFsplash10-0a4i-1001900000-68715e57f4cd013994a92021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Alisertib 40V, Negative-QTOFsplash10-053u-5002900000-c4fd5bce26cd550242ae2021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB05220
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID24700147
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkAlisertib
METLIN IDNot Available
PubChem Compound24771867
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]